166 related articles for article (PubMed ID: 33664225)
1. Hepatic HuR protects against the pathogenesis of non-alcoholic fatty liver disease by targeting PTEN.
Tian M; Wang J; Liu S; Li X; Li J; Yang J; Zhang C; Zhang W
Cell Death Dis; 2021 Mar; 12(3):236. PubMed ID: 33664225
[TBL] [Abstract][Full Text] [Related]
2. Reduced hepatic lipid content in Pten-haplodeficient mice because of enhanced AKT2/PKBβ activation in skeletal muscle.
Schultze SM; Dietrich M; Hynx D; Geier A; Niessen M; Spinas GA; Hemmings BA; Tschopp O
Liver Int; 2015 Apr; 35(4):1354-66. PubMed ID: 24845341
[TBL] [Abstract][Full Text] [Related]
3. HuR promotes triglyceride synthesis and intestinal fat absorption.
Liu C; Lin Y; Wang Y; Lin S; Zhou J; Tang H; Yi X; Ma Z; Xia T; Jiang B; Tian F; Ju Z; Liu B; Gu X; Yang Z; Wang W
Cell Rep; 2024 May; 43(5):114238. PubMed ID: 38748875
[TBL] [Abstract][Full Text] [Related]
4. Hepatic HuR modulates lipid homeostasis in response to high-fat diet.
Zhang Z; Zong C; Jiang M; Hu H; Cheng X; Ni J; Yi X; Jiang B; Tian F; Chang MW; Su W; Zhu L; Li J; Xiang X; Miao C; Gorospe M; de Cabo R; Dou Y; Ju Z; Yang J; Jiang C; Yang Z; Wang W
Nat Commun; 2020 Jun; 11(1):3067. PubMed ID: 32546794
[TBL] [Abstract][Full Text] [Related]
5. The RNA binding protein human antigen R is a gatekeeper of liver homeostasis.
Subramanian P; Gargani S; Palladini A; Chatzimike M; Grzybek M; Peitzsch M; Papanastasiou AD; Pyrina I; Ntafis V; Gercken B; Lesche M; Petzold A; Sinha A; Nati M; Thangapandi VR; Kourtzelis I; Andreadou M; Witt A; Dahl A; Burkhardt R; Haase R; Domingues AMJ; Henry I; Zamboni N; Mirtschink P; Chung KJ; Hampe J; Coskun Ü; Kontoyiannis DL; Chavakis T
Hepatology; 2022 Apr; 75(4):881-897. PubMed ID: 34519101
[TBL] [Abstract][Full Text] [Related]
6. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
7. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.
Edmunds LR; Xie B; Mills AM; Huckestein BR; Undamatla R; Murali A; Pangburn MM; Martin J; Sipula I; Kaufman BA; Scott I; Jurczak MJ
Mol Metab; 2020 Nov; 41():101051. PubMed ID: 32653576
[TBL] [Abstract][Full Text] [Related]
8. Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt.
Kenerson HL; Subramanian S; McIntyre R; Kazami M; Yeung RS
PLoS One; 2015; 10(2):e0117000. PubMed ID: 25646773
[TBL] [Abstract][Full Text] [Related]
9. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.
Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH
Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245
[TBL] [Abstract][Full Text] [Related]
10. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.
Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH
J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886
[TBL] [Abstract][Full Text] [Related]
11. Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in
Ray M; Gabunia K; Vrakas CN; Herman AB; Kako F; Kelemen SE; Grisanti LA; Autieri MV
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1297-1308. PubMed ID: 29674474
[TBL] [Abstract][Full Text] [Related]
12. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
Thakuri LS; Park CM; Kim HA; Kim HJ; Park JW; Park JC; Rhyu DY
J Ethnopharmacol; 2024 Feb; 320():117395. PubMed ID: 37952731
[TBL] [Abstract][Full Text] [Related]
13. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
[TBL] [Abstract][Full Text] [Related]
14. Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice.
Singh AB; Dong B; Kraemer FB; Xu Y; Zhang Y; Liu J
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2448-2459. PubMed ID: 30354208
[TBL] [Abstract][Full Text] [Related]
15. Adipose HuR protects against diet-induced obesity and insulin resistance.
Li J; Gong L; Liu S; Zhang Y; Zhang C; Tian M; Lu H; Bu P; Yang J; Ouyang C; Jiang X; Wu J; Zhang Y; Min Q; Zhang C; Zhang W
Nat Commun; 2019 May; 10(1):2375. PubMed ID: 31147543
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
Zhang H; Shen Z; Lin Y; Zhang J; Zhang Y; Liu P; Zeng H; Yu M; Chen X; Ning L; Mao X; Cen L; Yu C; Xu C
J Biol Chem; 2020 Mar; 295(12):3891-3905. PubMed ID: 32051143
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway.
Riaz F; Chen Q; Lu K; Osoro EK; Wu L; Feng L; Zhao R; Yang L; Zhou Y; He Y; Zhu L; Du X; Sadiq M; Yang X; Li D
J Cell Mol Med; 2021 Apr; 25(8):4073-4087. PubMed ID: 33689215
[TBL] [Abstract][Full Text] [Related]
18. GCSF deficiency attenuates nonalcoholic fatty liver disease through regulating GCSFR-SOCS3-JAK-STAT3 pathway and immune cells infiltration.
Zhang Y; Zhou X; Liu P; Chen X; Zhang J; Zhang H; Li S; Chen Y; Song X; Wang J; Zeng H; Zhang X; Tang C; Yu C; Li Y; Xu C
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G531-G542. PubMed ID: 33470903
[TBL] [Abstract][Full Text] [Related]
19. Autotaxin Expression Is Regulated at the Post-transcriptional Level by the RNA-binding Proteins HuR and AUF1.
Sun S; Zhang X; Lyu L; Li X; Yao S; Zhang J
J Biol Chem; 2016 Dec; 291(50):25823-25836. PubMed ID: 27784781
[TBL] [Abstract][Full Text] [Related]
20. Oral intake of genetically engineered high-carotenoid corn ameliorates hepatomegaly and hepatic steatosis in PTEN haploinsufficient mice.
Eritja N; Arjó G; Santacana M; Gatius S; Ramírez-Núñez O; Arcal L; Serrano JCE; Pamplona R; Dolcet X; Piñol C; Christou P; Matias-Guiu X; Portero-Otin M
Biochim Biophys Acta; 2016 Apr; 1862(4):526-535. PubMed ID: 26820774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
